๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Twenty years of follow-up of aortohepatic conduits in liver transplantation

โœ Scribed by Dmitriy Nikitin; Linda W. Jennings; Tariq Khan; Edmund Q. Sanchez; Srinath Chinnakotla; Henry B. Randall; Greg J. McKenna; Robert M. Goldstein; Marlon F. Levy; Goran B. Klintmalm


Publisher
John Wiley and Sons
Year
2008
Tongue
English
Weight
119 KB
Volume
14
Category
Article
ISSN
1527-6465

No coin nor oath required. For personal study only.

โœฆ Synopsis


Arterial problems remain a formidable challenge in liver transplantation. In many situations, an aortohepatic conduit can provide a solution. No long-term results (over 5 years) have been reported. This study was designed to assess the impact of aortohepatic conduits on graft survival after liver transplantation and the safety of aortohepatic conduits and to establish the long-term results (up to 20 years) of aortohepatic conduits. Data from 2346 adult liver transplants were prospectively collected into the computerized database and analyzed. In the majority of cases, arterial conduits were constructed from the donor iliac artery obtained at the liver retrieval. Aortohepatic conduits were required in 149 (6.4%) first transplants. The long-term graft survival after liver transplantation using aortohepatic conduits was excellent and comparable to that of the control group. The graft survival was 59% with the conduit versus 67% without the conduit at 5 years of follow-up, 50% versus 52% at 10 years, and 33% versus 35% at 15 years. With up to 20 years of follow-up, there was no statistically significant difference in graft survival, patient survival, hepatic artery complications, or biliary complications. For the same time period, there was no statistically significant difference in graft survival or patient survival for the retransplants with and without aortohepatic conduits. In conclusion, in experienced hands, aortohepatic conduits can be used safely for liver transplantation with no negative impact on long-term graft survival, patient survival, hepatic artery complications, or biliary complications. Excellent long-term results can be obtained.


๐Ÿ“œ SIMILAR VOLUMES


Twenty years' follow-up of portal vein c
โœ Dmitriy Nikitin; Linda W. Jennings; Tariq Khan; Sugam Vasani; Richard Ruiz; Edmu ๐Ÿ“‚ Article ๐Ÿ“… 2009 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 222 KB ๐Ÿ‘ 1 views

Portal vein problems remain a formidable challenge in liver transplantation. In select situations, a portal vein conduit can provide a solution. No long-term results have been reported. This study was designed to assess the impact of portal vein conduits on graft survival after liver transplantation

Graft fibrosis after pediatric liver tra
โœ Rene Scheenstra; Paul M.G.J. Peeters; Henkjan J. Verkade; Annette S. H. Gouw ๐Ÿ“‚ Article ๐Ÿ“… 2008 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 156 KB ๐Ÿ‘ 1 views

Previously we reported the presence of portal fibrosis in 31% (n = 84) of the grafts in protocol biopsies 1 year after pediatric liver transplantation (LTx). To assess the natural history of graft fibrosis after pediatric liver transplantation, we extended the analysis of graft histology in follow-u

Quality of life up to 30 years following
โœ Rajendra Desai; Neville V. Jamieson; Alexander E. Gimson; Christopher J. Watson; ๐Ÿ“‚ Article ๐Ÿ“… 2008 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 155 KB ๐Ÿ‘ 1 views

Liver transplantation provides a return to a satisfactory quality of life (QOL) for the majority of patients in the short to medium term (first 5 years), but there is very little information on the QOL in the longer term and the factors influencing it. We therefore undertook a single-center cross-se

Follow-up of Chinese liver transplant re
โœ Sheung Tat Fan; Haibo Wang; Banny K. Lam ๐Ÿ“‚ Article ๐Ÿ“… 2009 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 302 KB ๐Ÿ‘ 1 views

The outcome of liver transplantation in China remains speculative. From 1998 to 2007, 177 adult Hong Kong patients underwent liver transplantation in China and were subsequently followed up at Queen Mary Hospital, Hong Kong. One hundred six (59.9%) patients had hepatocellular carcinoma (HCC). The gr

Hepatitis C genotypes in liver transplan
โœ Zein, Nizar N. ;Rakela, Jorge ;Poterucha, John J. ;Steers, Jeffery L. ;Wiesner, ๐Ÿ“‚ Article ๐Ÿ“… 1995 ๐Ÿ› Wiley (John Wiley & Sons) ๐ŸŒ English โš– 355 KB ๐Ÿ‘ 1 views

Chronic hepatitis C infection (CH-C) accounts for a significant number of patients undergoing orthotopic liver transplantation (OLT). Recently, hepatitis C virus (HCV) genotype-dependent differences in disease outcome and therapeutic responses have been suggested. The objectives of our study were to

Early cyclosporine monotherapy in liver
โœ Luca S. Belli; Luciano de Carlis; Gianfranco Rondinara; Alberto B. Alberti; Gior ๐Ÿ“‚ Article ๐Ÿ“… 1998 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 89 KB ๐Ÿ‘ 2 views

Maintenance of adequate immunosuppression and avoidance of side-effects are the goals of long-term management of all organ-transplanted patients. We here report the final results of a prospective, randomized trial comparing early cyclosporine monotherapy versus double-drug therapy (cyclosporine and